We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > products

News List

NMPA releases 2nd group of key projects for China’s drug regulatory science action plan October 25, 2021
The National Medical Products Administration (NMPA) issued a list of the second group of key projects for China's drug regulatory science action plan based on the summary of the implementation of the first group on June 24.
Astrea Bioseparations makes critical infrastructure investments in Cambridge, UK and Singapore PharmaSources.com
September 18, 2021
Cambridge, UK – September 16, 2021 – Astrea Bioseparations, a leading provider of bioseparations products and services, today announced two new investments to enhance operations and customer support resources.
Emerging NMR techniques as advanced tools for characterising biological parenteral products europeanpharmaceuticalreview
May 21, 2019
Emerging NMR techniques as advanced tools for characterising biological parenteral products.
Novartis obtains rights to use Parvus’ Navacim to develop products for T1D pharmaceutical-technology
April 24, 2017
Biopharmaceutical company Parvus Therapeutics has entered a licence and collaboration agreement with Novartis for its lead, Navacim, to treat type 1 diabetes (T1D).